The COVID-19 pandemic has accelerated the adoption of telepractice in speech therapy, providing valuable insights into its efficacy and user satisfaction. A recent study, "Factors affecting telepractice use in COVID-19," sheds light on the variables influencing telepractice adoption and offers practical recommendations for practitioners.
Key Findings from the Research
The study conducted a cross-sectional mixed-method analysis involving 70 patients and caregivers in Singapore. The primary factors influencing telepractice adoption were:
- Convenience: Telepractice saved travel time and reduced waiting periods.
- Ease of Use: Users found the technology straightforward and user-friendly.
- Improved Access: Telepractice enhanced healthcare accessibility, particularly during pandemic restrictions.
- Safety: Reduced exposure to COVID-19 was a significant motivator.
Despite high satisfaction rates, some participants expressed reluctance to continue telepractice post-pandemic due to technical disruptions and a perceived lack of personal touch.
Practical Recommendations for Practitioners
Based on the study's findings, practitioners can enhance their telepractice skills by focusing on the following areas:
- Technological Infrastructure: Ensure stable internet connections and high-quality video conferencing tools to minimize disruptions.
- User Training: Provide comprehensive training for both patients and caregivers to navigate telepractice platforms effectively.
- Guideline Development: Create clear protocols and guidelines to streamline telepractice sessions and address common technical issues.
Encouraging Further Research
While the study provides valuable insights, further research is needed to explore the long-term sustainability of telepractice and its impact on diverse populations. Practitioners are encouraged to participate in ongoing research and share their experiences to contribute to the growing body of knowledge in telehealth.
To read the original research paper, please follow this link: Factors affecting telepractice use in COVID-19.
